This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
This month, the editors of AACR’s journals picked studies highlighting genetic parallels between cancer evolution and high-altitude physiology, data...
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
Twenty-one years ago this week, police officers, firefighters, paramedics, and volunteers converged on the remains of the World Trade...
At the end of last week, the U.S. Food and Drug Administration (FDA) announced the approval of the first...
A young adult shares his story of leaving college and learning to rely on his mother as he battled...
Last week, the U.S. Food and Drug Administration (FDA) added another therapeutic to the armamentarium for hematologist-oncologists when it...
Check out the 10 blog posts from 2014 that attracted the most attention. They cover a lot of ground,...